Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,643,827
+$3,645,970 QoQ
Shares Held
134,203
+164.5% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#238
of 1,408 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $207,447,311 across 14 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
111,326 | $60,319,766 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,326,678 | $44,947,850 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
205,677 | $34,664,801 | |
| 4 | VTRS |
Viatris Inc
|
1,698,341 | $26,969,655 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
134,203 | $9,643,827 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
65,941 | $7,315,494 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
491,057 | $4,910,570 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
866,285 | $4,270,785 |
All Filings in ZTS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,643,827 | 134,203 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,997,857 | 50,739 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $22,969,573 | 182,559 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,376,621 | 125,592 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,984,698 | 64,025 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $23,715,198 | 144,034 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $16,031,008 | 98,392 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,118,534 | 51,789 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $14,339,472 | 82,715 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,226,037 | 60,434 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $4,037,203 | 20,455 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,615,711 | 84,008 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $17,046,551 | 98,987 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,804,067 | 40,880 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,055,038 | 27,670 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $2,501,171 | 14,551 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $505,044 | 2,678 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $339,201 | 1,390 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,758,520 | 9,058 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,092,092 | 21,958 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $258,014 | 1,559 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||